4+ day, 15+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

5+ day, 20+ hour ago   (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its ​experimental cardiovascular drug ziltivekimab, further ‌denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...

1+ week, 3+ day ago   (206+ words) BRUSSELS, Sept 3 (Reuters) – Heatwaves from June 18 through August 16 caused 2,935 excess deaths in Belgium, or 22.6% ​excess mortality, public health body ‌Sciensano said in a report on Thursday. • From June 18 through July 3, Belgium recorded its highest excess mortality, with 2,035 additional deaths, or…...

1+ week, 4+ day ago   (257+ words) Sept 1 (Reuters) – Almost 2,150 people are thought to have died from heat-related causes in Spain in August, official data showed on Tuesday, ​after record-breaking heatwaves engulfed Western Europe during ‌the summer. • Data on the Health Ministry’s daily mortality monitoring system MoMo…...

1+ week, 4+ day ago   (356+ words) COPENHAGEN, Sep 1 (Reuters) – Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday, with investors keenly focused on the oral weight-loss treatment in ​light of intensifying competition with U.S. rival Eli…...

2+ week, 6+ day ago   (168+ words) Aug 24 (Reuters) – Eli Lilly said on Monday it has launched its oral pill, Foundayo, in ​the UK for weight ‌management and type 2 diabetes, making it the first country in Europe where the treatment is available. • ‌The ​pill, known chemically ⁠as…...